Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 4,695 | 1,064 | 0 | 0 | 0 |
| Gross Profit | 4,695 | 1,064 | N/A | N/A | N/A |
| Operating Expenses | 37,337 | 36,011 | 34,863 | 36,968 | 37,221 |
| Operating Income | -32,642 | -34,947 | -34,863 | -36,968 | -37,221 |
| Other Income | 2,584 | 3,062 | 1,589 | 2,254 | 2,233 |
| Pre-tax Income | -30,058 | -31,885 | -33,274 | -34,714 | -34,988 |
| Income Tax | 252 | 83 | -22 | 170 | 190 |
| Net Income Continuous | -30,310 | -31,968 | -33,252 | -34,884 | -35,178 |
| Net Income | $-30,310 | $-31,968 | $-33,252 | $-34,884 | $-35,178 |
| EPS Basic Total Ops | -0.43 | -0.53 | -0.57 | -0.70 | -0.71 |
| EPS Basic Continuous Ops | -0.43 | -0.53 | -0.57 | -0.70 | -0.71 |
| EPS Diluted Total Ops | -0.43 | -0.53 | -0.57 | -0.70 | -0.71 |
| EPS Diluted Continuous Ops | -0.43 | -0.53 | -0.57 | -0.70 | -0.71 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -0.53 | -0.58 | N/A | N/A |
| EBITDA(a) | $-30,582 | $-33,050 | $-33,017 | $-35,134 | $-35,830 |